Dermavant Sciences Ltd License Agreements
10 Contracts & Agreements
- Sublicense Agreement, dated as of December 17, 2018, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH, relating to the License Agreement by and between Roivant... (Filed With SEC on May 24, 2019)
- Assignment and Assumption Agreement, dated as of December 17, 2018, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH, relating to the License Agreement by and... (Filed With SEC on May 24, 2019)
- Sublicense Agreement, dated as of December 17, 2018, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH, relating to the License Agreement by and between Roivant... (Filed With SEC on May 24, 2019)
- Assignment and Assumption Agreement, dated as of December 17, 2018, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH, relating to the License Agreement by and... (Filed With SEC on May 24, 2019)
- License Agreement, dated as of January 31, 2018, by and between Roivant Sciences GmbH and TheraVida, Inc (Filed With SEC on May 24, 2019)
- License Agreement, dated as of September 19, 2017, by and between Roivant Sciences GmbH and AstraZeneca AB (Filed With SEC on May 24, 2019)
- First Amendment, dated as of July 7, 2017, to the License Agreement, dated as of December 16, 2016, by and between Dermavant Sciences GmbH and Portola Pharmaceuticals, Inc (Filed With SEC on May 24, 2019)
- License Agreement, dated as of December 16, 2016, by and between Dermavant Sciences GmbH and Portola Pharmaceuticals, Inc (Filed With SEC on May 24, 2019)
- First Amendment, dated as of July 7, 2017, to the License Agreement, dated as of November 19, 2015, by and between Dermavant Sciences GmbH and Eisai Co., Ltd (Filed With SEC on May 24, 2019)
- License Agreement, dated November 19, 2015, by and between Dermavant Sciences GmbH and Eisai Co., Ltd (Filed With SEC on May 24, 2019)
